May 7 |
Entrada Therapeutics GAAP EPS of $0.68, revenue of $59.12M
|
May 7 |
Entrada Therapeutics Reports First Quarter 2024 Financial Results
|
Apr 11 |
Insiders Buying America's Car-Mart And 2 Other Stocks
|
Mar 27 |
Director Peter Kim Acquires 9,048 Shares of Entrada Therapeutics Inc (TRDA)
|
Mar 22 |
Around $5M Bet On This Communication Services Stock? Check Out These 4 Stocks Insiders Are Buying
|
Mar 19 |
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates
|
Mar 15 |
Entrada Therapeutics Inc (TRDA) Reports Solid Financial Position and Advancements in Clinical Trials
|
Mar 14 |
Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M
|
Mar 13 |
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 21 |
Entrada Therapeutics CEO discloses sale of 1K shares
|